- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03462433
Treatment of Ruptured Intracranial Aneurysms in China.
The Safety and Efficacy of Ruptured Intracranial Aneurysms Embolized Assisted With Stents(SERIAES).
Ruptured intracranial aneurysms is currently a common disease that seriously affects human health and quality of life due to its high morbidity,high mortality and high disability. At present,Ruptured intracranial aneurysms are treated with craniotomy clipping and interventional embolization ,but for ruptured wide-neck intracranial aneurysms, the treatment of craniotomy clipping and coiling embolization are not effective.With the improvement of endovascular treatment materials and techniques, three dimensional coil basket technique, double microcatheter technique, balloon assisted ONYX embolization, simple stent covered aneurysm neck, balloon or stent assisted neck remodeling and coil embolization are used in endovascular treatment of ruptured wide-neck intracranial aneurysms. The treatment methods are different in the intervention effect of ruptured wide-neck intracranial aneurysms, for example, the complications of interventional therapy are lower than craniotomy clipping,but the rate of well functional outcome (mRS ≤2) differed significantly by 3 months follow-up (65.0% vs.75.0%), and there is not standard of treatment in different parts of ruptured wide-neck intracranial aneurysms in our country, the choice of interventional therapy or craniotomy clipping are different in different clinical centers; on the other hand, there are serious problems in the treatment of ruptured wide-neck intracranial aneurysms, because without the relevant guidelines of diagnosis and treatment of ruptured wide-neck intracranial aneurysms, different clinical centers will cause excessive treatment of ruptured wide-neck intracranial aneurysms, not only bring unreasonable utilization of medical resources, but also cause the subject's life and property to be threatened.
The patients with ruptured wide-neck intracranial aneurysms(n=1084) and unruptured intracranial aneurysms(n=300) were included in prospective cohort study, after interventional therapy and craniotomy clipping, setting fixed time for postoperative follow-up, the clinical data and image data were recorded, the safety, efficacy and economic benefits of interventional treatment and craniotomy clipping were compared, providing strategies for the standardized treatment of ruptured wide-neck intracranial aneurysms.
Studieoversikt
Status
Detaljert beskrivelse
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiekontakt
- Navn: Wenxian Zeng, M.D
- Telefonnummer: +86-013926290871
- E-post: 602057619@qq.com
Studer Kontakt Backup
- Navn: Xifeng Li, PH. D
- Telefonnummer: +86-018620993755
- E-post: nflxf@126.com
Studiesteder
-
-
Guangdong
-
Guangzhou, Guangdong, Kina, 510282
- Southern Medical University, Zhujiang Hospital
-
Ta kontakt med:
- Xuying He, PH. D
- Telefonnummer: +86-013688877133
- E-post: hexuyingzj@163.com
-
Ta kontakt med:
- Wenxian Zeng, M.D
- Telefonnummer: 86-013926290871
- E-post: 602057619@qq.com
-
Hovedetterforsker:
- Xuying He, PH. D
-
Underetterforsker:
- Wenxian Zeng, M.D
-
Underetterforsker:
- Xin Zhang, PH. D
-
Underetterforsker:
- Xifeng Li, PH. D
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- At least one imaging methods( CTA/ MRA/DSA ) confirmed ruptured wide-neck intracranial aneurysms (fundus-to-neck ratio < 2 or neck diameter > 4 mm );
- Stent-Assisted Coiling of un-ruptured intracranial aneurysms, whether have clinical symptoms or no;
- For multiple aneurysms, regardless of previous treatment, the requirement for treatment interval should >6 months;
- The subjects age 14 years;
- subjects or family members agree to sign informed consent.
Exclusion Criteria:
- Subjects with other intracranial vascular malformations, such as AVM, AVF. Etc;
- Subjects with malignant tumors in the intracranial or other parts of the body;
- Fusiform, traumatic, bacterial or dissecting aneurysm;
- Subjects with severe mental illness unable to communicate when diagnosing disease;
- The body condition is poor, the survival time is less than 1 year or poor physical condition, cannot tolerate the general anesthesia or aneurysm surgery;
- Subjects involved in other intracranial aneurysms related clinical research;
- A patient who received surgical clipping or endovascular treatment at once;
- Subjects who were not followed up;
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
The safety evaluation of interventional therapy and craniotomy clipping.
Tidsramme: 6 months later after operation.
|
2.The safety evaluation including the mortality(mRS=6) rate and disability(3<mRS<6) rate of subjects.
|
6 months later after operation.
|
The safety evaluation of interventional therapy and craniotomy clipping.
Tidsramme: 6 months later after operation.
|
The safety evaluation including the mortality(mRS=6) rate of subjects.
|
6 months later after operation.
|
Modified Rankin score ( mRS ).
Tidsramme: 1 year.
|
0. completely silent.
|
1 year.
|
Raymond classification.
Tidsramme: 1 year.
|
|
1 year.
|
The effectiveness evaluation of craniotomy clipping.
Tidsramme: 6 months later after operation.
|
The effectiveness evaluation including the complete occlusion( Raymond classification=1) rate of aneurysms.
|
6 months later after operation.
|
The effectiveness evaluation of interventional treatment.
Tidsramme: 6 months later after operation.
|
The effectiveness evaluation including the recurrence ( Raymond classification =3) rate of aneurysms.
|
6 months later after operation.
|
The effectiveness evaluation of craniotomy clipping.
Tidsramme: 6 months later after operation.
|
The effectiveness evaluation including the recurrence( Raymond classification=3) rate of aneurysms.
|
6 months later after operation.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
The safety evaluation interventional therapy.
Tidsramme: 12 months later after operation.
|
The safety evaluation including the mortality( mRS=6)rate and disability(3<mRS<6 ) rate of subjects.
|
12 months later after operation.
|
The effectiveness evaluation of interventional treatment.
Tidsramme: 12 months later after operation.
|
The effectiveness evaluation including the complete occlusion( Raymond classification=1 ) rate of aneurysms.
|
12 months later after operation.
|
The success rate of treatment.
Tidsramme: 6 months later after operation.
|
Angiography revealed total or near total occlusion of aneurysm in 6 months after operation, no recurrence of aneurysm was found.
the treatment was considered successful.
|
6 months later after operation.
|
The incidence of major adverse events after 3 months of surgery.
Tidsramme: 3 months.
|
3 months.
|
|
The incidence of major adverse events in 3 months and 6 months later after operation.
Tidsramme: 3 months and 6 months later after operation.
|
3 months and 6 months later after operation.
|
|
The incidence of major adverse events in 6 months and 12 months later after operation.
Tidsramme: 6 months and 12 months later after operation.
|
6 months and 12 months later after operation.
|
|
The safety evaluation of craniotomy clipping.
Tidsramme: 12 months later after operation.
|
The safety evaluation including the mortality( MRS=6 ) rate and disability(3<MRS <6) rate of subjects.
|
12 months later after operation.
|
The effectiveness evaluation of interventional treatment.
Tidsramme: 12 months later after operation.
|
The effectiveness evaluation including the recurrence( Raymond classification=3 ) rate of aneurysms.
|
12 months later after operation.
|
The effectiveness evaluation of craniotomy clipping.
Tidsramme: 12 months later after operation.
|
The effectiveness evaluation including the complete occlusion( Raymond classification=1 ) rate of aneurysms.
|
12 months later after operation.
|
The effectiveness evaluation of craniotomy clipping.
Tidsramme: 12 months later after operation.
|
The effectiveness evaluation including the recurrence( Raymond classification=3) rate of aneurysms.
|
12 months later after operation.
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Xuying He, PH. D, Study Principal Investigator Department of Neurosurgery, Southern Medical University, Zhujiang Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2016YFC1300800
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Ubrutt intrakranielle aneurismer
-
Tanta UniversityFullførtLUF - Luteinisert unruptured follicle syndromeEgypt
-
Stryker NeurovascularRekruttering
-
Jeil Pharmaceutical Co., Ltd.Fullført
-
Xiyuan Hospital of China Academy of Chinese Medical...Dongzhimen Hospital, Beijing; Beijing Hospital of Traditional Chinese Medicine og andre samarbeidspartnereUkjentPolycystisk ovariesyndrom | Hyperprolaktinemi | Anovulatorisk infertilitet | Unormale uterin blødning-ovulationsforstyrrelser | Luteinisert unruptured follicle syndrome | Corpus luteum insuffisiens | Ovarial insuffisiens